1236404-98-0

Upstream product

• 99-76-3 methyl 4-hydroxylbenzoate 
• 124391-75-9 3-tetrahydrofuranmethanol 

Downstream Products

• 1236403-69-2 N-(3-{[(2-hydroxy-2-methylpropyl)amino]methyl}-8-methylquinolin-7-yl)-4-(tetrahydrofuran-3-ylmethoxy)benzamide 
• 1236403-72-7 N-{8-methyl-3-[(tetrahydro-2H-pyran-4-ylamino)methyl]quinolin-7-yl}-4-(tetrahydrofuran-3-ylmethoxy)benzamide 
• 1236403-86-3 N-{3-[(cyclopentylamino)methyl]-8-methylquinolin-7-yl}-4-(tetrahydrofuran-3-ylmethoxy)benzamide 
• 1236404-74-2 N-(8-methyl-3-{[(2-methylpropyl)amino]methyl}quinolin-7-yl)-4-(tetrahydrofuran-3-ylmethoxy)benzamide 
• 1236404-79-7 N-(3-{[(2,2-dimethylpropyl)amino]methyl}-8-methylquinolin-7-yl)-4-(tetrahydrofuran-3-ylmethoxy)benzamide 
• 1236404-80-0 N-(8-methyl-3-{[(tetrahydro-2H-pyran-4-ylmethyl)amino]methyl}quinolin-7-yl)-4-(tetrahydrofuran-3-ylmethoxy)benzamide 
• 1236404-84-4 N-{3-[(4-hydroxy-4-methylpiperidin-1-yl)methyl]-8-methylquinolin-7-yl}-4-(tetrahydrofuran-3-ylmethoxy)benzamide 
• 1236405-00-7 N-(3-formyl-8-methylquinolin-7-yl)-4-(tetrahydrofuran-3-ylmethoxy)benzamide 
• 1236403-70-5 N-(8-methyl-3-{[(1-methylethyl)amino]methyl}quinolin-7-yl)-4-(tetrahydrofuran-3-ylmethoxy)benzamide 
• 1236404-75-3 N-(8-methyl-3-{[(2-methylpropyl)amino]methyl}quinolin-7-yl)-4-((3R)-tetrahydrofuran-3-ylmethoxy)benzamide 
• 1236404-77-5 N-(8-methyl-3-{[(2-methylpropyl)amino]methyl}quinolin-7-yl)-4-((3S)-tetrahydrofuran-3-ylmethoxy)benzamide 
• 1236404-83-3 N-(3-{[(2-methoxy-2-methylpropyl)amino]methyl}-8-methylquinolin-7-yl)-4-(tetrahydrofuran-3-ylmethoxy)benzamide 
• 1314128-00-1 ethyl 1-methyl-5-({[4-(tetrahydrofuran-3-ylmethoxy)phenyl]carbonyl}amino)-1H-indole-2-carboxylate 
• 1314128-01-2 N-(2-formyl-1-methyl-1H-indol-5-yl)-4-(tetrahydrofuran-3-ylmethoxy)benzamide 

Relevant academic research and scientific papers

INDOLE DERIVATIVE

The present invention provides an indole derivative having a melanin-concentrating hormone receptor antagonistic action, which is useful as an agent for the prophylaxis or treatment of obesity and the like. The present invention relates to a compound represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof.

QUINOLINE DERIVATIVE

The present invention provides a compound having a melanin-concentrating hormone receptor antagonistic action and low toxicity, which is useful as an agent for the prophylaxis or treatment of obesity and the like. The present invention relates to a compound represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof.